MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 24, 2023, at 2 pm CET in the premises of the hotel Square … [Read more…]
MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Wednesday, May 10, 2023 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2023. Participants during the call will … [Read more…]
Oral presentation on SAR’579 / IPH6101, a potential first-in-class NKp46/CD16-based NK cell engager targeting CD123; SAR’579 / IPH6101 is ANKET® platform lead asset and under development by partner Sanofi Two Trial in Progress posters including monalizumab in non-small cell lung cancer, developed in collaboration with AstraZeneca MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: … [Read more…]
TORONTO–(BUSINESS WIRE)–Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), Canada’s on-demand virtual pharmacy, announced today that it is executing on cost reduction measures and operational streamlining to focus on operating a more efficient business. Asset-light model for select regions. Mednow has shifted from a strategy of owning the pharmacies in all its provinces, to operating and funding … [Read more…]
Novel Second-Generation SMA Gene Therapy Rescues Motor Function in Mice, Outperforms Benchmark Therapy BURLINGTON, Mass. & BEIJING–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that data on the novel second-generation gene therapy, developed under the CANbridge … [Read more…]
A portion of proceeds from the Peanut Butter MacroBar® benefits farm animal advocacy annually during the month of May. VIOLA, Wis.–(BUSINESS WIRE)–GoMacro®, known for its organic, plant-based nutrition bars, is excited to partner with Farm Sanctuary for the seventh year in a row. As the founding farm animal sanctuary in the United States, Farm Sanctuary … [Read more…]
PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a global, biopharmaceutical, company focused on developing and commercializing novel therapies for patients with severe diseases, today announced that it will report financial results for the first quarter ended March 31, 2023, and provide an update on the Company’s business operations … [Read more…]
Data on Scribe’s X-Editor technologies validates the high activity, specificity and deliverability achievable through CRISPR by Design™ ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc., a molecular engineering company creating genetic medicines through its CRISPR by Design™ approach to genetic modification, today announced a presentation on its X-Editor (XE) technology at the 26th American Society of Gene & … [Read more…]
ORMAND BEACH, Fla.–(BUSINESS WIRE)–Elite Learning, a market leading provider of continuing education for healthcare professionals, today announced the commemoration of Nurses Month in 2023 with five nursing continuing education (CE) courses offered at no cost for the month of May, along with helpful new resources to support nurses in their professional development. “We are so … [Read more…]
NORRISTOWN, Pa.–(BUSINESS WIRE)–Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis will be presented at the upcoming EuroPCR 2023 Conference. EuroPCR is an annual, world-leading conference on interventional cardiovascular medicine taking place from May … [Read more…]
